Wuxi Life International Holdings Group Limited
Wuxi Life International Holdings Group Limited Fundamental Analysis
Wuxi Life International Holdings Group Limited (8148.HK) shows weak financial fundamentals with a PE ratio of -219.32, profit margin of -13.63%, and ROE of -25.64%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -10.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze 8148.HK's fundamental strength across five key dimensions:
Efficiency Score
Weak8148.HK struggles to generate sufficient returns from assets.
Valuation Score
Excellent8148.HK trades at attractive valuation levels.
Growth Score
Weak8148.HK faces weak or negative growth trends.
Financial Health Score
Excellent8148.HK maintains a strong and stable balance sheet.
Profitability Score
Weak8148.HK struggles to sustain strong margins.
Key Financial Metrics
Is 8148.HK Expensive or Cheap?
P/E Ratio
8148.HK trades at -219.32 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, 8148.HK's PEG of 0.24 indicates potential undervaluation.
Price to Book
The market values Wuxi Life International Holdings Group Limited at 54.56 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at -247.16 times EBITDA. This is generally considered low.
How Well Does 8148.HK Make Money?
Net Profit Margin
For every $100 in sales, Wuxi Life International Holdings Group Limited keeps $-13.63 as profit after all expenses.
Operating Margin
Core operations generate -10.56 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-25.64 in profit for every $100 of shareholder equity.
ROA
Wuxi Life International Holdings Group Limited generates $-8.98 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Wuxi Life International Holdings Group Limited generates limited operating cash flow of $-7.88M, signaling weaker underlying cash strength.
Free Cash Flow
Wuxi Life International Holdings Group Limited generates weak or negative free cash flow of $-7.96M, restricting financial flexibility.
FCF Per Share
Each share generates $-0.02 in free cash annually.
FCF Yield
8148.HK converts -0.54% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-219.32
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.24
vs 25 benchmark
P/B Ratio
Price to book value ratio
54.56
vs 25 benchmark
P/S Ratio
Price to sales ratio
30.07
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.005
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.50
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.26
vs 25 benchmark
ROA
Return on assets percentage
-0.09
vs 25 benchmark
ROCE
Return on capital employed
-0.19
vs 25 benchmark
How 8148.HK Stacks Against Its Sector Peers
| Metric | 8148.HK Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -219.32 | 33.61 | Better (Cheaper) |
| ROE | -25.64% | 1020.00% | Weak |
| Net Margin | -13.63% | -56528.00% (disorted) | Weak |
| Debt/Equity | 0.00 | 0.45 | Strong (Low Leverage) |
| Current Ratio | 1.50 | 5.65 | Neutral |
| ROA | -8.98% | -291484.00% (disorted) | Weak |
8148.HK outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Wuxi Life International Holdings Group Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Growth, Innovation, High Beta
EPS CAGR
N/A
Industry Style: Growth, Innovation, High Beta
FCF CAGR
N/A
Industry Style: Growth, Innovation, High Beta